the symptoms of Meniere's disease (MD) are generally considered to be related to endolymphatic hydrops (eH). there are many recent reports supporting the possibility that vasopressin (Vp) is closely linked to the formation of eH in Meniere's disease. Based on this, we developed a clinically relevant animal model of Meniere's disease in which a VP type 2 receptor agonist was administered after electrocauterization of the endolymphatic sac. We report live imaging of the internal structure, and functional changes of the inner ear after electrocauterization of the endolymphatic sac and administration of a VP type 2 receptor agonist. In this model, the development of EH was visualized in vivo using optical coherence tomography, there was no rupture of Reissner's membrane, and lowtone hearing loss and vertiginous attacks were observed. this study suggested that acute attacks are caused by the abrupt development of EH. This is the first report of live imaging of the development of EH induced by the administration of a VP type 2 receptor agonist. Meniere's disease (MD) is a well-known inner ear disorder characterized by several symptoms, including recurring attacks of vertigo typically lasting for hours, fluctuating sensorineural hearing loss, and tinnitus. In the early stage of MD, hearing loss usually involves the low frequencies. MD is histologically characterized by endolymphatic hydrops (EH) in the inner ear 1,2. There is considerable evidence that water homeostasis in the inner ear is partly regulated via the vasopressin-aquaporin 2 (VP-AQP2) system 3-13 as follows: (1) plasma levels of arginine VP are higher in patients with MD and may depend on the phase that the patient is in 3,5,6 , (2) acute and chronic application of arginine VP produces EH in guinea pigs and rats 4,7,10 , (3) V2 receptor mRNA is expressed in the rat and human inner ear 8,11-13 , and (4) expression of V2 receptor mRNA in the rat inner ear is down-regulated by VP application 9. Since the discovery of aquaporin (AQP) water channels 14 , precise regulation of water reabsorption was proposed to largely depend on the regulation of AQP2 channels and water permeability may there fore change rapidly in response to vasopressin (VP) in the kidney 15. Such evidence led to the assumption that the production of endolymph is controlled by the VP-AQP2 system in the inner ear. If this is the case, EH, a morphological characteristic of MD, reflects the misregulation of the VP-AQP2 system in inner ear fluid. Based on human and experimental studies, we recently developed a more suitable animal model of MD 16. This model consists of the combination of endolymphatic sac dysfunction and administration of a vasopressin type 2 receptor agonist (desmopressin). Although episodes of imbalance were rarely observed in previous models of EH, vertigo was observed in our new animal model. Moreover, we recently visualized the internal structure of the inner ear using optical coherence tomography (OCT) in vitro 17. OCT uses low-coherence interferometry to produce a two-dimens...